Internal Medicine, Hematology & Oncology · Jacksonville, FL
NPI
1922095884
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
7751 Baymeadows Rd E Ste 205
Jacksonville, FL, 32256
Phone (904) 427-1050
Groups this clinician bills Medicare through
Medicare paid, 2024
$59K
814 services
Medicare patients, 2024
437
Average age 74
Drug cost, 2024
$993K
626 prescriptions
Company payments, 2025
$452
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Carlos M Castillo was code 99214 (office e&m - established), 287 times for 153 patients. In total Carlos M Castillo billed 814 services in 10 codes, and Medicare paid $59K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-06-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 287 | 153 | $71.01 | $20K |
| 99213 Office E&M - Established | Facility | 222 | 178 | $46.25 | $10K |
| 99222 Hospital E&M - Initial | Facility | 79 | 78 | $105.23 | $8,313 |
| 99232 Hospital E&M - Subsequent | Facility | 78 | 62 | $62.20 | $4,852 |
| 99223 Hospital E&M - Initial | Facility | 41 | 41 | $133.68 | $5,481 |
| 99233 Hospital E&M - Subsequent | Facility | 31 | 26 | $95.68 | $2,966 |
| 99204 Office E&M - New | Facility | 27 | 27 | $100.78 | $2,721 |
| 99203 Office E&M - New | Facility | 21 | 21 | $63.23 | $1,328 |
By year: 2022 $73K for 1,024 services; 2023 $68K for 923 services; 2024 $59K for 814 services.
Medicare prescription drug claims, 2024
In 2024, the drug Carlos M Castillo prescribed most often to Medicare patients was Eliquis (Apixaban), with 121 prescriptions and refills. In total Carlos M Castillo wrote 626 Medicare prescriptions that cost $993K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 121 | 185 | 22 | $106K |
| Letrozole Generic | 61 | 113 | 15 | $1,150 |
| Hydroxyurea Generic | 34 | 65 | 11 | $284 |
| Tamoxifen Citrate Generic | 28 | 40 | Under 11 | $522 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 25 | 25 | Under 11 | $1,131 |
| Jantoven Warfarin Sodium | 18 | 37 | Under 11 | $228 |
| Anastrozole Generic | 17 | 17 | Under 11 | $154 |
| Xarelto Rivaroxaban | 14 | 21 | Under 11 | $11K |
| Oxycodone Hcl Generic | 14 | 14 | Under 11 | $655 |
| Kisqali Femara Co-Pack Ribociclib Succinate/Letrozole | 14 | 14 | Under 11 | $150K |
| Everolimus Generic | 13 | 13 | Under 11 | $6,702 |
| Ondansetron Odt Ondansetron | 12 | 12 | Under 11 | $264 |
| Morphine Sulfate Er Morphine Sulfate | 12 | 12 | Under 11 | $621 |
| Hydromorphone Hcl Generic | 12 | 12 | Under 11 | $219 |
| Cometriq Cabozantinib S-Malate | 12 | 12 | Under 11 | $270K |
Brand drugs: 216 claims; generic drugs: 410 claims; opioid claims: 69.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Carlos M Castillo $452 ($452 in general payments such as food, travel and fees) from 4 companies. The largest payer was Amgen Inc. with $154.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.